Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2964 (LINC02964) is a member of the long intergenic non-coding RNA (lincRNA) class, which are RNA transcripts longer than 200 nucleotides that do not code for proteins and are located between protein-coding genes in the genome[1][3]. LincRNAs, including LINC02964, can regulate gene expression through interactions with chromatin-modifying complexes or RNA-binding proteins, though the specific biological function and disease relevance of LINC02964 have not been established in the current literature[1][3][5]. This gene does not encode a therapeutic target such as an enzyme, receptor, channel, or transporter, and there is no evidence of direct involvement in disease, drug interactions, or biomarker utility based on currently available sources[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2964 (LINC02964).